Premium
Src promotes EGF‐induced epithelial‐to‐mesenchymal transition and migration in gastric cancer cells by upregulating ZEB1 and ZEB2 through AKT
Author(s) -
Zhao Lei,
Li Xin,
Song Na,
Li Aodi,
Hou Kezuo,
Qu Xiujuan,
Che Xiaofang,
Liu Yunpeng
Publication year - 2018
Publication title -
cell biology international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.932
H-Index - 77
eISSN - 1095-8355
pISSN - 1065-6995
DOI - 10.1002/cbin.10894
Subject(s) - proto oncogene tyrosine protein kinase src , protein kinase b , epithelial–mesenchymal transition , downregulation and upregulation , ly294002 , cancer research , chemistry , epidermal growth factor , mapk/erk pathway , cancer cell , microbiology and biotechnology , stat3 , signal transduction , biology , cancer , receptor , biochemistry , genetics , gene
Epithelial‐to‐mesenchymal transition (EMT) plays important roles in the migration, invasion, and metastasis of cancer cells. However, the role of Src in epidermal growth factor (EGF)‐induced EMT and migration in gastric cancer cells remains to be clarified. In the current study, the effect of Src on EGF‐stimulated EMT and migration was explored in gastric cancer cells. EGF induced EMT in gastric cancer cells and increased their migratory ability, which was accompanied by the phosphorylation of Src. PP2, the Src inhibitor, markedly suppressed EGF‐mediated EMT and migration in gastric cancer cells. Additionally, EGF‐stimulated upregulation of zinc finger E‐box binding homeobox 1 (ZEB1) and zinc finger E‐box binding homeobox 2 (ZEB2) was significantly repressed by PP2. Further analysis showed that EGF‐stimulated phosphorylation of protein kinase B (AKT) was almost completely abolished by PP2, whereas that of extracellular signal‐regulated kinase (ERK), signal transducer and activator of transcription 3 (STAT3) was only mildly suppressed. Moreover, LY294002, the AKT inhibitor, significantly inhibited EGF‐induced upregulation of ZEB1 and ZEB2 as well as EMT and migration stimulated by EGF in gastric cancer cells. However, neither ERK inhibitor nor STAT3 inhibitor repressed EGF‐induced EMT‐related changes. Taken together, these results suggest that Src promotes EGF‐stimulated EMT and migration by upregulation of ZEB1 and ZEB2 through AKT signaling pathway in gastric cancer cells.